Monoclonal antibodies currently in Phase II and III trials for multiple myeloma
Author:
Publisher
Informa Healthcare
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
http://www.tandfonline.com/doi/pdf/10.1517/14712598.2014.908848
Reference101 articles.
1. Multiple Myeloma
2. Improved survival in multiple myeloma and the impact of novel therapies
3. Hematopoietic stem cell transplantation for multiple myeloma beyond 2010
4. Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Immunotherapy in Multiple Myeloma: Accelerating on the Path to the Patient;Clinical Lymphoma Myeloma and Leukemia;2019-06
2. Immunomodulatory Functions of the Gastrointestinal Tract;Gastrointestinal Physiology;2018
3. CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma;Oncotarget;2017-10-30
4. Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometry;Cytometry Part B: Clinical Cytometry;2017-09-19
5. Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?;Immunotherapy;2016-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3